Schisandrin B Alleviates Lipid Metabolism Disorders and Apoptosis of MAFLD via Modulation of PPARγ-PCK1 and Caspase-3 Signaling Pathways. The gene discussed is CASP3; the disease is Disorder of lipid metabolism.